Elekta AB Class B
EKTAF
Market Cap$1.83B
Close$
$5.43
8.9% upside
Current Fair Value
8.9% upsideUndervalued by 8.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $6.44 Billion |
| Dividend Yield | $0.23 (0.54%) |
| Earnings per Share | $0.62 |
| Beta | 1.08 |
| Outstanding Shares | 382,178,218 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 717.24 |
|---|---|
| PEG | -371.6 |
| Price to Sales | 0.11 |
| Price to Book Ratio | 0.22 |
| Enterprise Value to Revenue | 0.36 |
| Enterprise Value to EBIT | 6.82 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 1.17 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Elekta AB
CEO: Gustaf Salford Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology in...